Quick Takeaways
- Susan Moran has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $20,399.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Susan Moran
- Location
- Los Altos, CA
- Summary
- The estimated net worth of Susan Moran is at least $20,399 dollars as of 23 Jun 2025. Susan Moran is the Director of BioAtla, Inc. and owns shares of BioAtla, Inc. (BCAB) stock worth about $20.4K.
- Signature
- /s/ Barbara Bispham, as attorney-in-fact for Susan Moran
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Susan Moran and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: BioAtla, Inc. ($20,399).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Susan Moran
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BCAB | BioAtla, Inc. | Director | $20,399 | 18 Jun 2025 | ||
| RYZB | RayzeBio, Inc. | Chief Medical Officer | $0 | 26 Feb 2024 | ||
| CBIO | GLYCOMIMETICS INC | Director | 23 Jun 2025 | |||
| TYRA | Tyra Biosciences, Inc. | Director | 29 May 2025 |
Insider Transactions Reported by Susan Moran:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.